News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,534 Results
Type
Article (43779)
Company Profile (274)
Press Release (675481)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (208427)
Career Advice (2101)
Deals (35990)
Drug Delivery (101)
Drug Development (82461)
Employer Resources (174)
FDA (16796)
Job Trends (15173)
News (352590)
Policy (33525)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2718)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (51132)
ALS (95)
Alzheimer's disease (1414)
Antibody-drug conjugate (ADC) (128)
Approvals (16794)
Artificial intelligence (264)
Autoimmune disease (25)
Automation (16)
Bankruptcy (362)
Best Places to Work (11885)
BIOSECURE Act (19)
Biosimilars (108)
Biotechnology (197)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (284)
Cancer (2298)
Cardiovascular disease (177)
Career advice (1751)
Career pathing (31)
CAR-T (157)
Cell therapy (434)
Cervical cancer (20)
Clinical research (66943)
Collaboration (857)
Compensation (526)
Complete response letters (21)
COVID-19 (2669)
CRISPR (42)
C-suite (247)
Cystic fibrosis (102)
Data (2215)
Decentralized trials (2)
Denatured (19)
Depression (45)
Diabetes (273)
Diagnostics (6526)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (107)
Drug shortages (26)
Duchenne muscular dystrophy (93)
Earnings (87489)
Editorial (36)
Employer branding (21)
Employer resources (148)
Events (115028)
Executive appointments (731)
FDA (18055)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (775)
Gene editing (111)
Generative AI (22)
Gene therapy (313)
GLP-1 (721)
Government (4566)
Grass and pollen (4)
Guidances (59)
Healthcare (19460)
Huntington's disease (23)
IgA nephropathy (29)
Immunology and inflammation (122)
Indications (29)
Infectious disease (2812)
Inflammatory bowel disease (137)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (96)
Interviews (323)
IPO (16672)
IRA (42)
Job creations (3699)
Job search strategy (1488)
Kidney cancer (11)
Labor market (38)
Layoffs (472)
Leadership (18)
Legal (8096)
Liver cancer (77)
Lung cancer (328)
Lymphoma (157)
Machine learning (7)
Management (59)
Manufacturing (311)
MASH (66)
Medical device (13949)
Medtech (13954)
Mergers & acquisitions (19860)
Metabolic disorders (691)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (27)
Neuroscience (1968)
NextGen: Class of 2025 (6781)
Non-profit (4615)
Northern California (2684)
Now hiring (39)
Obesity (367)
Opinion (213)
Ovarian cancer (76)
Pain (90)
Pancreatic cancer (84)
Parkinson's disease (152)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (48)
People (58450)
Pharmaceutical (66)
Pharmacy benefit managers (20)
Phase I (20918)
Phase II (29480)
Phase III (21921)
Pipeline (1196)
Policy (142)
Postmarket research (2606)
Preclinical (8966)
Press Release (69)
Prostate cancer (106)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (389)
Real estate (6054)
Recruiting (66)
Regulatory (22977)
Reports (46)
Research institute (2449)
Resumes & cover letters (366)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (70)
Series A (135)
Series B (90)
Service/supplier (12)
Sickle cell disease (52)
Southern California (2307)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3694)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (37)
The Weekly (30)
United States (23261)
Vaccines (714)
Venture capitalists (41)
Weight loss (239)
Women's health (35)
Worklife (15)
Date
Today (107)
Last 7 days (865)
Last 30 days (2632)
Last 365 days (33323)
2025 (10676)
2024 (35799)
2023 (40808)
2022 (51978)
2021 (56630)
2020 (55199)
2019 (47979)
2018 (36147)
2017 (33123)
2016 (32602)
2015 (38725)
2014 (32437)
2013 (27611)
2012 (29799)
2011 (30434)
2010 (28426)
Location
Africa (762)
Alabama (53)
Alaska (7)
Arizona (234)
Arkansas (13)
Asia (39484)
Australia (6454)
California (6140)
Canada (2015)
China (526)
Colorado (270)
Connecticut (286)
Delaware (146)
Europe (85983)
Florida (910)
Georgia (211)
Idaho (61)
Illinois (540)
India (26)
Indiana (307)
Iowa (11)
Japan (161)
Kansas (106)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (904)
Massachusetts (4609)
Michigan (217)
Minnesota (399)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (66)
New Jersey (1731)
New Mexico (29)
New York (1751)
North Carolina (982)
North Dakota (8)
Northern California (2684)
Ohio (205)
Oklahoma (14)
Oregon (36)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1147)
South Carolina (22)
South Dakota (1)
Southern California (2307)
Tennessee (102)
Texas (905)
Utah (182)
Virginia (147)
Washington D.C. (62)
Washington State (564)
West Virginia (3)
Wisconsin (53)
719,534 Results for "delcath systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - March 14, 2025
March 17, 2025
·
2 min read
Press Releases
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
March 24, 2025
·
2 min read
Press Releases
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
April 28, 2025
·
4 min read
Press Releases
Delcath Systems Reports Fourth Quarter and Full Year 2024 Results
March 6, 2025
·
11 min read
Business
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to the Company’s Board of Directors effective May 23, 2024.
May 28, 2024
·
4 min read
Press Releases
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma
April 10, 2025
·
5 min read
Press Releases
Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call
February 20, 2025
·
2 min read
Business
Delcath Systems Reports First Quarter 2024 Results and Business Highlights
Delcath Systems, Inc. today reported financial results and business highlights for the first quarter ended March 31, 2024.
May 14, 2024
·
9 min read
Business
Delcath Systems to Host First Quarter 2024 Earnings Call
Delcath Systems, Inc. announced it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2024.
May 7, 2024
·
2 min read
Deals
Delcath Systems Closes $7 Million Private Placement
Delcath Systems, Inc. confirmed the closing of the previously announced private placement with certain accredited investors comprised of existing investors.
March 20, 2024
·
5 min read
1 of 71,954
Next
